Evaluating the effectiveness and cost-effectiveness of a digital, app-based intervention for depression (VMood) in community-based settings in Vietnam: Protocol for a stepped-wedge randomized controlled trial.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 15 05 2023
accepted: 02 08 2023
medline: 7 9 2023
pubmed: 5 9 2023
entrez: 5 9 2023
Statut: epublish

Résumé

The COVID-19 pandemic has amplified mental health problems and highlighted inequitable gaps in care worldwide. In response there has been an explosion of digital interventions such as smartphone applications ("apps") to extend care. The objective of this trial is to evaluate the effectiveness and cost-effectiveness of a digital depression intervention (VMood), delivered via a smartphone app. VMood is adapted from an in-person intervention that was delivered by non-specialist providers and shown to be effective in the Vietnamese context in our previous trial (2016-2019). A stepped-wedge, randomized controlled trial will be conducted across eight provinces in Vietnam. Adults aged 18 years and over will be recruited through community-based primary care centres and screened for depression using the embedded Patient Health Questionnaire-9 (primary outcome measure). Participants scoring 10-19, indicating depression caseness, will be randomly allocated to the intervention or control group until the target of 336 is reached. Secondary outcome measures will examine the effect of the intervention on commonly co-occuring anxiety, quality of life and work productivity, along with use of alcohol and tobacco products. Assessments will be administered through an online survey platform (REDCap) at baseline, and at every 3 months until 3 months post-intervention. Intervention-group participants will receive VMood for a 3-month period, with online support provided by social workers. Control-group participants will receive a limited version of the app until they cross into the intervention group. Generalized Linear Mixed-effect Models for clustered measures will be used for all outcomes data. We will conduct a cost-effectiveness analysis alongside the trial to capture VMood's costs and benefits. This trial will provide evidence on the effectiveness and cost-effectiveness of a digital mental health intervention adapted from an in-person intervention. This trial will also contribute important information to the growing and promising field of digital mental health. Trail regulation. Registered at ClinicalTrials.gov, identifier [NCT05783531].

Identifiants

pubmed: 37669289
doi: 10.1371/journal.pone.0290328
pii: PONE-D-23-13219
pmc: PMC10479903
doi:

Banques de données

ClinicalTrials.gov
['NCT05783531']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0290328

Subventions

Organisme : CIHR
ID : PJT 178156
Pays : Canada

Informations de copyright

Copyright: © 2023 Chau et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2019 Aug 20;14(8):e0221432
pubmed: 31430339
Lancet Psychiatry. 2017 Jun;4(6):486-500
pubmed: 28433615
J Gay Lesbian Ment Health. 2016;20(2):173-191
pubmed: 27642381
BMJ. 1999 Jul 10;319(7202):120
pubmed: 10398643
Can J Psychiatry. 2012 Apr;57(4):203-9
pubmed: 22480584
Front Psychiatry. 2021 Jan 08;11:589618
pubmed: 33488422
Lancet. 2018 Oct 27;392(10157):1553-1598
pubmed: 30314863
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
World Psychiatry. 2021 Oct;20(3):318-335
pubmed: 34505369
Soc Sci Med. 2014 Oct;118:33-42
pubmed: 25089962
Value Health. 2015 Mar;18(2):161-72
pubmed: 25773551
J Rural Health. 2018 Dec;34(1):48-62
pubmed: 28084667
Psychol Med. 1998 May;28(3):551-8
pubmed: 9626712
Lancet Psychiatry. 2021 Jun;8(6):535-550
pubmed: 33639109
Bull World Health Organ. 2004 Nov;82(11):858-66
pubmed: 15640922
NPJ Digit Med. 2019 Dec 2;2:118
pubmed: 31815193
Comput Methods Programs Biomed. 2018 Oct;164:207-220
pubmed: 30195428
Asian J Psychiatr. 2011 Mar;4(1):65-70
pubmed: 23050918
Int J Ment Health Syst. 2020 Feb 12;14:8
pubmed: 32071614
Prev Med. 2021 Apr;145:106333
pubmed: 33509605
JMIR Mhealth Uhealth. 2020 May 29;8(5):e17458
pubmed: 32348289
J Affect Disord. 2013 Apr 5;146(2):213-9
pubmed: 23026129
Alcohol Alcohol. 2002 Jan-Feb;37(1):61-6
pubmed: 11825859
JAMA. 2016 Sep 13;316(10):1093-103
pubmed: 27623463
Am Fam Physician. 2005 Oct 15;72(8):1503-10
pubmed: 16273817
Stat Med. 1991 Jan;10(1):45-52
pubmed: 2006355
J Affect Disord. 2021 Apr 1;284:157-182
pubmed: 33601245
World Psychiatry. 2020 Feb;19(1):3-14
pubmed: 31922693
Lancet. 2011 Nov 5;378(9803):1654-63
pubmed: 22008420
Qual Life Res. 2020 Jul;29(7):1923-1933
pubmed: 32221805
Am J Psychiatry. 2020 May 1;177(5):365-367
pubmed: 32354270
BMJ. 2015 Feb 06;350:h391
pubmed: 25662947
Lancet Psychiatry. 2016 May;3(5):415-24
pubmed: 27083119
Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
Value Health. 2013 Mar-Apr;16(2):231-50
pubmed: 23538175
Int J Equity Health. 2021 Jul 12;20(1):161
pubmed: 34253198
Qual Life Res. 2021 Mar;30(3):647-673
pubmed: 33284428
Pharmacoeconomics. 2008;26(11):969-81
pubmed: 18850765
Lancet. 2007 Sep 8;370(9590):878-89
pubmed: 17804062
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
JMIR Ment Health. 2020 Mar 26;7(3):e18848
pubmed: 32213476
Med Decis Making. 2012 Sep-Oct;32(5):678-89
pubmed: 22990083
Lancet Psychiatry. 2016 Feb;3(2):171-8
pubmed: 26851330
Curr HIV/AIDS Rep. 2021 Jun;18(3):176-185
pubmed: 33743138
Pharmacoecon Open. 2017 Sep;1(3):149-165
pubmed: 29441493
Stat Med. 2022 Jun 15;41(13):2448-2465
pubmed: 35274333
Int J Ment Health Syst. 2021 May 29;15(1):52
pubmed: 34051848
Pharmacoeconomics. 2004;22(3):165-84
pubmed: 14871164
Health Serv Insights. 2017 Mar 28;10:1178632917694350
pubmed: 28469456

Auteurs

Leena W Chau (LW)

Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada.

Jill K Murphy (JK)

Faculty of Medicine, Department of Psychiatry, The University of British Columbia, Vancouver, Canada.

Vu Cong Nguyen (VC)

Institute of Population, Health and Development, Hanoi, Vietnam.

Hui Xie (H)

Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada.

Raymond W Lam (RW)

Faculty of Medicine, Department of Psychiatry, The University of British Columbia, Vancouver, Canada.

Harry Minas (H)

Global and Cultural Mental Health Unit, Centre for Mental Health, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia.

Yufei Zheng (Y)

Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada.

Emanuel Krebs (E)

Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada.

Kanna Hayashi (K)

Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada.

Son Dao (S)

Institute of Population, Health and Development, Hanoi, Vietnam.

Xuan Nguyen (X)

Institute of Population, Health and Development, Hanoi, Vietnam.

Viet Anh Duong (VA)

Institute of Population, Health and Development, Hanoi, Vietnam.

Eugene Fiume (E)

Faculty of Applied Sciences, Simon Fraser University, Vancouver, Canada.

John O'Neil (J)

Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH